Biomodulatory metronomic therapy induces PET-negative remission in chemo- and brentuximab-refractory Hodgkin lymphoma. [electronic resource]
Producer: 20160509Description: 290-3 p. digitalISSN:- 1365-2141
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Brentuximab Vedotin
- Drug Administration Schedule
- Female
- Hodgkin Disease -- drug therapy
- Humans
- Immunoconjugates -- administration & dosage
- Immunologic Factors -- administration & dosage
- Male
- Positron-Emission Tomography
- Remission Induction
- Salvage Therapy -- methods
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.